Day two at ACR 2022 was full of great sessions on imaging, vasculitis, lupus, vasculitis, spondyloarthritis, COVID, pregnancy, microbiome, economics and more.
Here are the RheumNow faculty selections for #ACRbest abstracts today:
RT @uptoTate: DAVIX is a promising surrogate outcome measure of vascular disease in SSc. Questions around cost and acces
Tweet Content
DAVIX is a promising surrogate outcome measure of vascular disease in SSc. Questions around cost and access remain. Abs 1541 #ACR22 @RheumNow https://t.co/KJgtcG5ah8 https://t.co/NsK7b8fQFt
Links
MRI Digital Artery Volume Index (DAVIX) Predicts Future Digital Ulcers and Diseā¦
http://ow.ly/cvfL50Lzf9c